SCI Pharmtech Inc
TWSE:4119
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Salesforce Inc
NYSE:CRM
|
Technology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
UK |
Endava PLC
NYSE:DAVA
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Citigroup Inc
NYSE:C
|
Banking
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Fortinet Inc
NASDAQ:FTNT
|
Technology
|
|
US |
Intel Corp
NASDAQ:INTC
|
Semiconductors
|
|
US |
Starbucks Corp
NASDAQ:SBUX
|
Hotels, Restaurants & Leisure
|
|
US |
Copart Inc
NASDAQ:CPRT
|
Commercial Services & Supplies
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
86.4
100
|
Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Salesforce Inc
NYSE:CRM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Endava PLC
NYSE:DAVA
|
UK | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
Coca-Cola Co
NYSE:KO
|
US | |
Citigroup Inc
NYSE:C
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Fortinet Inc
NASDAQ:FTNT
|
US | |
Intel Corp
NASDAQ:INTC
|
US | |
Starbucks Corp
NASDAQ:SBUX
|
US | |
Copart Inc
NASDAQ:CPRT
|
US |
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
SCI Pharmtech Inc
Revenue
|
1.3B
TWD
|
Cost of Revenue
|
-904.5m
TWD
|
Gross Profit
|
347.4m
TWD
|
Operating Expenses
|
-202.1m
TWD
|
Operating Income
|
145.3m
TWD
|
Other Expenses
|
-6.8m
TWD
|
Net Income
|
138.5m
TWD
|
Income Statement
SCI Pharmtech Inc
Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1 440
N/A
|
1 460
+1%
|
1 492
+2%
|
1 560
+5%
|
1 724
+10%
|
1 795
+4%
|
1 811
+1%
|
2 013
+11%
|
1 956
-3%
|
1 994
+2%
|
1 903
-5%
|
1 586
-17%
|
1 348
-15%
|
1 226
-9%
|
1 301
+6%
|
1 398
+7%
|
1 644
+18%
|
1 809
+10%
|
1 940
+7%
|
2 118
+9%
|
2 192
+3%
|
2 300
+5%
|
2 356
+2%
|
2 536
+8%
|
2 660
+5%
|
2 711
+2%
|
2 689
-1%
|
2 229
-17%
|
1 677
-25%
|
1 227
-27%
|
864
-30%
|
729
-16%
|
733
+1%
|
810
+10%
|
900
+11%
|
1 053
+17%
|
1 185
+13%
|
1 139
-4%
|
1 204
+6%
|
1 172
-3%
|
1 252
+7%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(986)
|
(993)
|
(1 013)
|
(1 042)
|
(1 114)
|
(1 157)
|
(1 155)
|
(1 235)
|
(1 172)
|
(1 167)
|
(1 113)
|
(987)
|
(888)
|
(857)
|
(905)
|
(972)
|
(1 069)
|
(1 120)
|
(1 191)
|
(1 235)
|
(1 299)
|
(1 364)
|
(1 420)
|
(1 508)
|
(1 495)
|
(1 492)
|
(1 415)
|
(1 217)
|
(1 012)
|
(796)
|
(656)
|
(561)
|
(541)
|
(598)
|
(609)
|
(694)
|
(807)
|
(773)
|
(854)
|
(853)
|
(904)
|
|
Gross Profit |
454
N/A
|
468
+3%
|
479
+2%
|
518
+8%
|
610
+18%
|
638
+5%
|
655
+3%
|
778
+19%
|
784
+1%
|
827
+5%
|
791
-4%
|
599
-24%
|
460
-23%
|
369
-20%
|
396
+7%
|
427
+8%
|
575
+35%
|
688
+20%
|
749
+9%
|
882
+18%
|
893
+1%
|
936
+5%
|
936
0%
|
1 029
+10%
|
1 165
+13%
|
1 219
+5%
|
1 274
+5%
|
1 012
-21%
|
665
-34%
|
431
-35%
|
208
-52%
|
167
-20%
|
193
+15%
|
212
+10%
|
291
+38%
|
359
+23%
|
379
+5%
|
366
-3%
|
350
-4%
|
319
-9%
|
347
+9%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(216)
|
(187)
|
(184)
|
(187)
|
(201)
|
(210)
|
(215)
|
(256)
|
(255)
|
(268)
|
(274)
|
(214)
|
(187)
|
(175)
|
(161)
|
(177)
|
(218)
|
(230)
|
(233)
|
(254)
|
(233)
|
(234)
|
(239)
|
(245)
|
(275)
|
(275)
|
(223)
|
(183)
|
(126)
|
(100)
|
(134)
|
(133)
|
(148)
|
(157)
|
(172)
|
(180)
|
(178)
|
(176)
|
(190)
|
(193)
|
(202)
|
|
Selling, General & Administrative |
(182)
|
(150)
|
(148)
|
(150)
|
(163)
|
(173)
|
(180)
|
(220)
|
(220)
|
(233)
|
(238)
|
(181)
|
(155)
|
(142)
|
(128)
|
(143)
|
(183)
|
(194)
|
(197)
|
(216)
|
(196)
|
(196)
|
(200)
|
(206)
|
(234)
|
(233)
|
(179)
|
(143)
|
(89)
|
(67)
|
(104)
|
(101)
|
(113)
|
(120)
|
(133)
|
(136)
|
(133)
|
(127)
|
(141)
|
(145)
|
(156)
|
|
Research & Development |
(34)
|
(37)
|
(36)
|
(37)
|
(38)
|
(37)
|
(35)
|
(36)
|
(36)
|
(36)
|
(36)
|
(33)
|
(33)
|
(33)
|
(33)
|
(34)
|
(35)
|
(35)
|
(37)
|
(37)
|
(38)
|
(39)
|
(39)
|
(39)
|
(40)
|
(42)
|
(43)
|
(30)
|
(26)
|
(22)
|
(30)
|
(32)
|
(35)
|
(37)
|
(40)
|
(43)
|
(45)
|
(49)
|
(49)
|
(48)
|
(46)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
239
N/A
|
281
+18%
|
295
+5%
|
331
+12%
|
409
+23%
|
428
+5%
|
440
+3%
|
521
+19%
|
529
+1%
|
559
+6%
|
516
-8%
|
385
-26%
|
272
-29%
|
194
-29%
|
235
+21%
|
249
+6%
|
357
+43%
|
459
+29%
|
516
+12%
|
629
+22%
|
660
+5%
|
702
+6%
|
697
-1%
|
784
+12%
|
891
+14%
|
944
+6%
|
1 052
+11%
|
829
-21%
|
539
-35%
|
331
-39%
|
74
-78%
|
35
-53%
|
45
+29%
|
55
+23%
|
119
+117%
|
180
+51%
|
200
+12%
|
190
-5%
|
160
-15%
|
127
-21%
|
145
+15%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
25
|
28
|
37
|
34
|
(8)
|
15
|
8
|
3
|
10
|
(20)
|
(11)
|
(12)
|
(10)
|
1
|
(9)
|
(7)
|
12
|
16
|
20
|
36
|
28
|
24
|
2
|
(21)
|
(33)
|
(49)
|
(42)
|
(31)
|
(42)
|
(29)
|
(16)
|
(9)
|
3
|
19
|
6
|
2
|
2
|
(4)
|
(13)
|
(4)
|
(0)
|
|
Gain/Loss on Disposition of Assets |
(2)
|
(0)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
(1)
|
(1)
|
(0)
|
(2)
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
(0)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
0
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
0
|
0
|
|
Total Other Income |
4
|
3
|
3
|
5
|
5
|
5
|
4
|
2
|
1
|
2
|
1
|
7
|
9
|
9
|
10
|
4
|
8
|
9
|
9
|
10
|
7
|
14
|
13
|
12
|
11
|
13
|
(554)
|
(556)
|
(549)
|
(554)
|
8
|
40
|
191
|
190
|
264
|
234
|
288
|
287
|
218
|
219
|
7
|
|
Pre-Tax Income |
266
N/A
|
312
+17%
|
335
+7%
|
369
+10%
|
405
+10%
|
446
+10%
|
451
+1%
|
527
+17%
|
540
+2%
|
539
0%
|
506
-6%
|
379
-25%
|
270
-29%
|
204
-24%
|
235
+15%
|
245
+5%
|
376
+53%
|
484
+29%
|
545
+13%
|
675
+24%
|
693
+3%
|
737
+6%
|
711
-4%
|
773
+9%
|
869
+12%
|
907
+4%
|
455
-50%
|
241
-47%
|
(52)
N/A
|
(252)
-389%
|
66
N/A
|
66
+0%
|
237
+261%
|
262
+11%
|
388
+48%
|
415
+7%
|
490
+18%
|
472
-4%
|
364
-23%
|
341
-6%
|
152
-55%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(49)
|
(58)
|
(70)
|
(75)
|
(79)
|
(86)
|
(78)
|
(89)
|
(95)
|
(95)
|
(89)
|
(68)
|
(50)
|
(38)
|
(44)
|
(45)
|
(66)
|
(88)
|
(98)
|
(125)
|
(134)
|
(145)
|
(140)
|
(158)
|
(170)
|
(179)
|
(95)
|
(48)
|
7
|
49
|
(10)
|
(10)
|
(45)
|
(52)
|
(79)
|
(83)
|
(100)
|
(95)
|
(69)
|
(66)
|
(14)
|
|
Income from Continuing Operations |
217
|
254
|
265
|
294
|
326
|
360
|
374
|
438
|
445
|
444
|
417
|
311
|
220
|
166
|
191
|
201
|
310
|
396
|
447
|
550
|
559
|
592
|
571
|
615
|
699
|
728
|
360
|
193
|
(44)
|
(203)
|
56
|
55
|
192
|
210
|
309
|
331
|
390
|
377
|
295
|
276
|
138
|
|
Net Income (Common) |
217
N/A
|
254
+18%
|
265
+4%
|
294
+11%
|
326
+11%
|
360
+11%
|
374
+4%
|
438
+17%
|
445
+2%
|
444
0%
|
417
-6%
|
311
-25%
|
220
-29%
|
166
-24%
|
191
+15%
|
201
+5%
|
310
+55%
|
396
+28%
|
447
+13%
|
550
+23%
|
559
+2%
|
592
+6%
|
571
-4%
|
615
+8%
|
699
+14%
|
728
+4%
|
360
-51%
|
193
-46%
|
(44)
N/A
|
(203)
-358%
|
56
N/A
|
55
-1%
|
192
+247%
|
210
+10%
|
309
+47%
|
331
+7%
|
390
+18%
|
377
-3%
|
295
-22%
|
276
-6%
|
138
-50%
|
|
EPS (Diluted) |
2.74
N/A
|
3.19
+16%
|
3.33
+4%
|
3.66
+10%
|
4.04
+10%
|
4.5
+11%
|
4.67
+4%
|
5.46
+17%
|
5.55
+2%
|
5.53
0%
|
4.35
-21%
|
3.89
-11%
|
2.74
-30%
|
2.07
-24%
|
1.99
-4%
|
2.52
+27%
|
3.89
+54%
|
4.97
+28%
|
4.64
-7%
|
6.86
+48%
|
6.99
+2%
|
7.38
+6%
|
5.93
-20%
|
7.68
+30%
|
7.29
-5%
|
7.57
+4%
|
3.27
-57%
|
2
-39%
|
-0.49
N/A
|
-2.14
-337%
|
0.51
N/A
|
0.58
+14%
|
2.01
+247%
|
1.95
-3%
|
2.81
+44%
|
3.01
+7%
|
3.57
+19%
|
3.44
-4%
|
2.69
-22%
|
2.3
-14%
|
1.15
-50%
|